Chemokines and cytokines: Axis and allies in asthma and allergy

Cytokine and Growth Factor Reviews

Volumn 14, Issue 6, 2003, Pages 503-510

  Schuh, Jane M ^a   Blease, Kate ^b   Kunkel, Steven L ^a   Hogaboam, Cory M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CELGENE CORPORATION   (United States)

Author keywords

Allergy; Asthma; Chemokine; Fungus; Inflammation

Indexed keywords

CHEMOKINE; CYTOKINE;

ALLERGY; ASPERGILLUS FUMIGATUS; ASTHMA; CELL ACTIVATION; CYTOKINE PRODUCTION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ACARI; BLATTARIA; FUNGI;

EID: 0142118158     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00057-1     Document Type: Review

References (68)

1. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002;277(42):39320-6.
2. Taub DD, Longo DL, Murphy WJ. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood 1996;87(4):1423-31.
3. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Lagaespada DA, Jenkins NA, et al. Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994;266:1395.
4. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997;387(6633):611-7.
5. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12(2):121-7.
6. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nat Med 1996;2:1174-8.
7. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
8. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to crosslinking FcER1 or to calcium ionophores. Nature 1989;339:64.
9. McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 1998;8(6):339-42.
10. Finkelman FD, Urban Jr JF. The other side of the coin: the protective role of the Th2 cytokines. J Allergy Clin Immunol 2001;107(5): 772-80.
11. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol Today 1991;12:49-53.
12. Denning DW. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 2001;7(Suppl 2):25-31.
13. Kurup VP, Seymour BWP, Choi H, Coffman RL. Particulate Aspergillus fumigatus antigens elicit a Th2 response in BALB/c mice. J Allergy Clin Immunol 1994;93:1013-20.
14. Hogaboam CM, Blease K, Mehrad B, Steinhauser ML, Standiford TJ, Kunkel SL, et al. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 2000;156:723-32.
15. Hanley-Lopez J, Clement LT. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Curr Opin Pulm Med 2000;6(6): 540-4.
16. Wark PA, Gibson PG. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology 2001;6(1):1-7.
17. Madan T, Arora N, Sarma PU. Identification and evaluation of a major cytotoxin of A. fumigatus. Mol Cell Biochem 1997;167(1-2):89-97.
18. Kauffman HF, Tomee JF, van der Werf TS, de Monchy JG, Koeter GK. Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 1995;151(6):2109-15. Discussion 2116.
19. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12(2):310-50.
20. Mehrad B, Strieter RM, Moore TA, Tsai WC, Lira SA, Standiford TJ. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol 1999; 163(11):6086-94.
21. Kurup VP, Choi H, Murali PS, Coffman RL. IgE and eosinophil regulation in a murine model of allergic aspergillosis. J Leukoc Biol 1994;56(5):593-8.
22. Hogaboam CM, Gallinat CS, Taub DD, Strieter RM, Kunkel SL, Lukacs NW. Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. J Immunol 1999;162(10):6071-9.
23. Kurup VP, Choi H, Murali PS, Resnick A, Fink JN, Coffman RL. Role of particulate antigens of Aspergillus in murine eosinophilia. Int Arch Allergy Immunol 1997;112(3):270-8.
24. Schuh JM, Blease K, Kunkel SL, Hogaboam CM. Eotaxin/CCL11 is involved in acute, but not chronic, allergic airway responses to Aspergillus fumigatus. Am J Physiol Lung Cell Mol Physiol 2002;283(1):L198-204.
25. Zimmermann N, Hogan SP, Mishra A, Brandt EB, Bodette TR, Pope SM, et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 2000;165(10):5839-46.
26. Blease K, Kunkel SL, Hogaboam CM. IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2. Inflamm Res 2001;50(11):552-60.
27. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997;185(6):1089-99.
28. Roilides E, Dimitriadou A, Kadiltsoglou I, Sein T, Karpouzas J, Pizzo PA, et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997;158(1):322-9.
29. Schuyler M. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med 1998;131(3):194-6.
30. Knutsen AP, Mueller KR, Levine AD, Chouhan B, Hutcheson PS, Slavin RG. Asp f1 CD4+ Th2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994;94(2 (Part 1)):215-21.
31. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994;150(4):1038-48.
32. Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr Pulmonol 1999;27(2):74-9.
33. Knutsen AP, Mueller KR, Hutcheson PS, Slavin RG. Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994;93(5):926-31.
34. Rathore VB, Johnson B, Fink JN, Kelly KJ, Greenberger PA, Kurup VP. T cell proliferation and cytokine secretion to T cell epitopes of Asp f2 in ABPA patients. Clin Immunol 2001;100(2):228-35.
35. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183(1):109-17.
36. Blease K, Schuh JM, Jakubzick C, Lukacs NW, Kunkel SL, Joshi BH, et al. Stat 6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 2002;160(2):481-90.
37. -/-mice and the effect of eosinophil ablation. Allergy 1999;54(5):420-7.
38. Murali PS, Kumar A, Choi H, Banasal NK, Fink JN, Kurup VP. Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody. J Leukoc Biol 1993;53(3):264-7.
39. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, et al. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998;4(5):344-55.
40. Blease K, Jakubzick C, Schuh JM, Joshi BH, Puri RK, Hogaboam CM. IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J Immunol 2001;167(11):6583-92.
41. Blease K, Jakubzick C, Westwick J, Lukacs N, Kunkel SL, Hogaboam CM. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 2001;166(8): 5219-24.
42. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997;176(1):300-3.
43. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105(6 (Part 1)):1185-93.
44. Christin L, Wysong DR, Meshulam T, Hastey R, Simons ER, Diamond RD. Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun 1998;66(3):1181-9.
45. -/- mice. J Immunol 2000;165(5):2603-11.
46. Blease K, Mehrad B, Lukacs NW, Kunkel SL, Standiford TJ, Hogaboam CM. Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. J Immunol 2001;166(3):1832-42.
47. Schuh JM, Blease K, Hogaboam CM. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 2002;168(3):1447-56.
48. -/- mice. FASEB J 2002;16(10):1313-5.
49. Schuh JM, Blease K, Hogaboam CM. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J 2002;16(2):228-30.
50. Borger P, Koeter GH, Timmerman JA, Vellenga E, Tomee JF, Kauffman HF. Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis 1999;180(4):1267-74.
51. Kurup VP, Murali PS, Guo J, Choi H, Banerjee B, Fink JN, et al. Anti-interleukin (IL)-4 and IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 1997;52(12):1215-21.
52. -/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages. J Immunol 2002;168(4): 1903-10.
53. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389(6652):737-42.
54. Clemons KV, Grunig G, Sobel RA, Mirels LF, Rennick DM, Stevens DA, et al. Role of IL- 10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000;122(2):186-91.
55. -/- mice during chronic fungal allergic airway disease. J Immunol 2000;165(3): 1564-72.
56. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15(1):19-26.
57. Nakanishi A, Morita S, Iwashita H, Sagiya Y, Ashida Y, Shirafuji H, et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001;98(9):5175-80.
58. Takeyama K, Jung B, Shim JJ, Burgel PR, Dao-Pick T, Ueki IF, et al. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 2001;280(1):L165-72.
59. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103(6):779-88.
60. Bianchi G, Sozzani S, Zlotnick A, Mantovani A, Allavena P. Migratory response of human NK cells to lymphotactin. Eur J Immunol 1996;26:3238.
61. Judson MA, Stevens DA. The treatment of pulmonary aspergilloma. Curr Opin Invest Drugs 2001;2(10):1375-7.
62. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000;30(4):696-709.
63. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342(11): 756-62.
64. Wild JS, Sur S. CpG oligonucleotide modulation of allergic inflammation. Allergy 2001;56(5):365-76.
65. Cardon LR, Burge C, Clayton DA, Karlin S. Pervasive CpG suppression in animal mitochondrial genomes. Proc Natl Acad Sci USA 1994;91(9):3799-803.
66. Manickan E, Karem KL, Rouse BT. DNA vaccines - a modern gimmick or a boon to vaccinology? Crit Rev Immunol 1997;17(2): 139-54.
67. Wells TN, Proudfoot AE. Chemokine receptors and their antagonists in allergic lung disease. Inflamm Res 1999;48(7):353-62.
68. Proudfoot AE, Wells TN, Clapham PR. Chemokine receptors - future therapeutic targets for HIV? Biochem Pharmacol 1999;57(5):451-63.